Boston Children's Hospital at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Boston Children's Hospital brings 4 presentations to SITC 2026 in Phoenix. Its program centres on engineered immune cells aimed at the ALK protein in lymphoma and Merkel cell carcinoma, plus AI-driven protein design. One distinctive item uses B cells, rather than T cells, fitted with a receptor against HER2 to fight breast cancer in mice.
| Organization | SITC 2026 Attendance |
|---|---|
Boston Children's Hospital Boston, MA | |
Pediatric academic medical center in Boston and a teaching hospital of Harvard Medical School. | Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Session Sat Nov 7 5:20pm–6:40pm AI-driven Protein Design to Enhance Cancer Immunotherapy
|
Instantly find 20 buyers from Boston Children's Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction